Terms: = Kidney tumors AND U2AF1, ENSG00000160201, 7307, Q01081, U2AFBP, U2AF35, RNU2AF1, RN, FP793, DKFZp313J1712 AND Diagnosis
48 results:
1. Efficacy and late kidney effects of nephron-sparing surgery in the management of unilateral Wilms tumor: a systematic review and meta-analysis.
Li S; Wang J; Li M; Zhang Z; Mi T; Wu X; Wang Z; Jin L; He D
Pediatr Surg Int; 2023 Dec; 40(1):29. PubMed ID: 38150145
[TBL] [Abstract] [Full Text] [Related]
2. Partial versus radical nephrectomy for complex renal mass: multicenter comparative analysis of functional outcomes (Rosula collaborative group).
Cerrato C; Meagher MF; Autorino R; Simone G; Yang B; Uzzo RG; Kutikov A; Porpiglia F; Capitanio U; Montorsi F; Porter J; Beksac AT; Puri D; Nguyen M; Wang L; Hakimi K; Dhanji S; Liu F; Cerruto MA; Pandolfo SD; Minervini A; Lau C; Monish A; Eun D; Mottrie A; Mir C; Sundaram C; Antonelli A; Kaouk J; Derweesh IH
Minerva Urol Nephrol; 2023 Aug; 75(4):425-433. PubMed ID: 37530659
[TBL] [Abstract] [Full Text] [Related]
3. Surgical Management and Oncologic Outcomes for Local Retroperitoneal Recurrence of Renal Cell Carcinoma After Radical Nephrectomy.
Huang J; Wang Y; Zhang C; Hu X; Wang P; Shi G; Dong L; Zhang J; Kong W; Chen Y; Xia D; Guo J; Xue W; Huang Y; He Z
Clin Genitourin Cancer; 2023 Apr; 21(2):315.e1-315.e7. PubMed ID: 36396584
[TBL] [Abstract] [Full Text] [Related]
4. Differential expression profiling of onco and tumor-suppressor genes from major-signaling pathways in Wilms' tumor.
Sahu DK; Singh N; Das M; Rawat J; Gupta DK
Pediatr Surg Int; 2022 Nov; 38(11):1601-1617. PubMed ID: 36107237
[TBL] [Abstract] [Full Text] [Related]
5. Special issue "The advance of solid tumor research in China": Presurgical therapy in the management of local retroperitoneal recurrence of renal cell carcinoma after radical nephrectomy.
Wang Y; Huang J; Zhang C; Hu X; Wang P; Shi G; Zhang J; Kong W; Chen Y; Huang Y; Ye D; Xia D; Guo J; He Z; Xue W
Int J Cancer; 2023 Jan; 152(1):24-30. PubMed ID: 35712762
[TBL] [Abstract] [Full Text] [Related]
6. Clinical, pathological and long-term oncologic outcomes of papillary type I vs. type II renal cell carcinoma.
Basile G; Rosiello G; Larcher A; Fallara G; Martini A; Re C; Cignoli D; Tian Z; Karakiewicz PI; Mottrie A; Bertini R; Necchi A; Raggi D; Salonia A; Briganti A; Montorsi F; Capitanio U
Urol Oncol; 2022 Aug; 40(8):384.e15-384.e21. PubMed ID: 35662498
[TBL] [Abstract] [Full Text] [Related]
7. Oncological outcomes of surgery for isolated retroperitoneal recurrence in renal cancer patients after radical nephrectomy.
Staník M; Poprach A; Littnerová S; Čapák I; Hulová M; Šebová N; Lakomý R; Jarkovský J; Doležel J
Urol Oncol; 2022 Mar; 40(3):111.e27-111.e34. PubMed ID: 34961683
[TBL] [Abstract] [Full Text] [Related]
8. Differentiating the clinical and computed tomography imaging features of mixed epithelial and stromal tumors of the kidney to establish a treatment plan.
Chen J; Liu H; Li M; Liu W; Masokano IB; Pei Y; Li W
J Appl Clin Med Phys; 2022 Jan; 23(1):e13486. PubMed ID: 34861098
[TBL] [Abstract] [Full Text] [Related]
9. Robotic surgery for cT2 kidney cancer: analysis of the National Cancer Database.
Suek T; Davaro F; Raza SJ; Hamilton Z
J Robot Surg; 2022 Jun; 16(3):723-729. PubMed ID: 34435278
[TBL] [Abstract] [Full Text] [Related]
10. Evaluation of functional outcome of bilateral kidney tumors after sequential surgery.
Kim JK; Kim H; Lee H; Oh JJ; Lee S; Hong SK; Kwak C; Byun SS
BMC Cancer; 2021 May; 21(1):592. PubMed ID: 34024273
[TBL] [Abstract] [Full Text] [Related]
11. Renal Primitive Neuroectodermal Tumor With Inferior Vena Cava Thrombus: Case Series and Literature Review of a Rare but Challenging Entity.
Xu C; Sun Z; Xiao R; He W; Ma L
Clin Genitourin Cancer; 2021 Oct; 19(5):e273-e279. PubMed ID: 33941490
[TBL] [Abstract] [Full Text] [Related]
12. The Consequences of Inadvertent Radical Nephrectomy in the Treatment of Upper Tract Urothelial Carcinoma.
Al Hussein Al Awamlh B; Shoag JE; Basourakos SP; Lewicki PJ; Posada L; Ma X; Raman JD; Shariat SF; Scherr D
Urology; 2021 Aug; 154():127-135. PubMed ID: 33766715
[TBL] [Abstract] [Full Text] [Related]
13. Neoadjuvant SABR for Renal Cell Carcinoma Inferior Vena Cava Tumor Thrombus-Safety Lead-in Results of a Phase 2 Trial.
Margulis V; Freifeld Y; Pop LM; Manna S; Kapur P; Pedrosa I; Christie A; Mohamad O; Mannala S; Singla N; Wait M; Bagrodia A; Woldu SL; Gahan J; Brugarolas J; Timmerman R; Hannan R
Int J Radiat Oncol Biol Phys; 2021 Jul; 110(4):1135-1142. PubMed ID: 33549705
[TBL] [Abstract] [Full Text] [Related]
14. Utilization of renal mass biopsy in patients with localized renal cell carcinoma: A population-based study utilizing the National Cancer Database.
Patel DN; Ghali F; Meagher MF; Javier-Desloges J; Patel SH; Soliman S; Hakimi K; Yuan J; Murphy J; Derweesh IH
Urol Oncol; 2021 Jan; 39(1):79.e1-79.e8. PubMed ID: 33160847
[TBL] [Abstract] [Full Text] [Related]
15. The role of percutaneous fine needle aspiration biopsy in the management of small renal masses without chance of nephron-sparing surgery.
Tong W; Lin X; Xu Y; Yan Y
Int Urol Nephrol; 2020 Dec; 52(12):2223-2228. PubMed ID: 32638215
[TBL] [Abstract] [Full Text] [Related]
16. Rapid exacerbation featuring acute leukemoid reaction after retrolaparoscopic nephrectomy: a rare case report of renal cell carcinoma with postoperative comprehensive genomic profiling.
Zhang X; Yan L; Yuan X; Bai T; Zhang L; Han S
World J Surg Oncol; 2020 Jul; 18(1):155. PubMed ID: 32631368
[TBL] [Abstract] [Full Text] [Related]
17. Small renal masses in Latin-American population: characteristics and prognostic factors for survival, recurrence and metastasis - a multi-institutional study from LARCG database.
Mourão TC; Abreu D; Carvalhal GF; Gueglio G; da Costa WH; Calsavara VF; Meza-Montoya L; Bengió RG; Scorticati C; Castillejos-Molina R; Rodríguez-Covarrubias F; Autran-Gómez AM; Campos-Salcedo JG; Nolazco A; Ameri C; Zampolli H; Langenhin R; Muguruza D; Machado MT; Mingote P; Clavijo J; Nogueira L; Clark O; Rovegno AR; Secin FP; Decia R; Guimarães GC; Glina S; Rodríguez-Faba O; Palou J; Zequi SC
BMC Urol; 2020 Jul; 20(1):85. PubMed ID: 32615971
[TBL] [Abstract] [Full Text] [Related]
18. Percutaneous Cryoablation for Stage 1 Renal Cell Carcinoma: Outcomes from a 10-year Prospective Study and Comparison with Matched Cohorts from the National Cancer Database.
Morkos J; Porosnicu Rodriguez KA; Zhou A; Kolarich AR; Frangakis C; Rodriguez R; Georgiades CS
Radiology; 2020 Aug; 296(2):452-459. PubMed ID: 32515677
[TBL] [Abstract] [Full Text] [Related]
19. Management of the Small Renal Mass: a 2020 Update.
Wilcox Vanden Berg RN; Basourakos SP; LaRussa S; McClure TD
Curr Oncol Rep; 2020 Jun; 22(7):69. PubMed ID: 32514631
[TBL] [Abstract] [Full Text] [Related]
20. Clinicopathological characteristics of renal solitary fibrous tumor: A single institution experience.
Fu W; Bing Q; JingJing Z; Lijian L; Zhibin X; Qijian D; Jiwen C
Medicine (Baltimore); 2019 Feb; 98(8):e14618. PubMed ID: 30813191
[TBL] [Abstract] [Full Text] [Related]
[Next]
